[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hematopoietic-neoplasm\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hematopoietic-neoplasm":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":27,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100561203",false,"NCT06587100","Wearable Activity Tracking to Curb Hospitalizations","Wearable Activity Tracking to Curb Hospitalizations (WATCH)","WATCH","Inclusion Criteria:\n\n* Age \\>= 18.\n* Eastern Cooperative Oncology Group (ECOG) performance status =\\\u003C 2.\n* Able to understand study procedures and to comply with them for the entire length of the study.\n* Ability of individual or legal guardian\u002Frepresentative to understand a written informed consent document, and the willingness to sign it.\n* Diagnosis of invasive malignancy.\n* Able to ambulate independently (without the assistance of a cane or walker).\n* Planned treatment with fractionated external beam radiotherapy over at least 5 days (no fractional requirement).\n* Not a previous participant on this protocol for subsequent courses.\n\nExclusion Criteria:\n\n* Participants bound to a wheelchair.\n* Participants unable to ambulate independently (needing assistance of cane or walker).","ALL","18 Years",{"count":19,"type":20},260,"ESTIMATED","OBSERVATIONAL","This study is being done to collect patient generated health data to predict the risk of patients needing emergency department visits or hospitalization before, during. and after receiving radiation therapy.",[24,25,26],"Hematopoietic Neoplasm","Malignant Solid Neoplasm","Lymphatic System Neoplasm",[28,29,30],"Activity tracking","Hospitalization prevention","Artificial Intelligence (AI) modelling","RECRUITING","2026-04-14",{"date":34,"type":35},"2026-04-17","ACTUAL",{"date":37,"type":35},"2025-04-07",{"date":39,"type":20},"2027-12-31",{"name":41,"class":42},"University of California, San Francisco","OTHER",""]